Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2015-09-21

• Fields of study

  Biology, Medicine, Materials Science

• Identifiers
  DOI 10.1073/pnas.1510533112PMID 26392546PMCID PMC4603490
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9

  2015cited by this paper
• Design and self-assembly of simple coat proteins for artificial viruses.

  2014cited by this paper
• History of vaccination

  2014cited by this paper
• Activities at the Universal Protein Resource (UniProt)

  2013cited by this paper
• Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein

  2013influential reference
• Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice

  2013cited by this paper
• Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines

  2013cited by this paper
• Escherichia coli‐based cell free production of flagellin and ordered flagellin display on virus‐like particles

  2013cited by this paper
• Construction and Characterization of Virus-Like Particles: A Review

  2012cited by this paper
• Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry.

  2011cited by this paper
• The Pfam protein families database

  2011cited by this paper
• HBV Core Region Variability: Effect of Antiviral Treatments on Main Epitopic Regions

  2011cited by this paper
• Microscale to Manufacturing Scale-up of Cell-Free Cytokine Production—A New Approach for Shortening Protein Production Development Timelines

  2011cited by this paper
• Versatile Virus-Like Particle Carrier for Epitope Based Vaccines

  2010cited by this paper
• Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different Routes

  2009cited by this paper
• Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.

  2007cited by this paper
• The Pfam protein families database

  2007cited by this paper
• Hepatitis B virus infection--natural history and clinical consequences.

  2004cited by this paper
• A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.

  2004cited by this paper
• HBV Core Particles as a Carrier for B Cell/T Cell Epitopes

  2001cited by this paper
• Keyhole limpet hemocyanin (KLH): a biomedical review.

  1999cited by this paper
• The crystal structure of the human hepatitis B virus capsid.

  1999cited by this paper
• Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

  1987cited by this paper
• History of Vaccination.

  year unknowncited by this paper

• EPIclip: A Novel Approach for the Production of Decorated Virus-Like Particles Mediated by High-Affinity Protein Binding Partners.

  2026cites this paper
• Virus-like particles: a versatile and effective vaccine platform

  2025cites this paper
• Application of a novel virus-like particle platform to the development of Neisseria vaccines.

  2025cites this paper
• Chimeric hepatitis B core virus-like particles displaying the receptor-binding domain of porcine deltacoronavirus elicit protective immunity in piglets.

  2025cites this paper
• Reconstituting alternative life using the test-bed of cell-free systems

  2025cites this paper
• Modular Virus-like Particles for Antigen Presentation: Comparing Genetic Fusion and Click-Chemistry for Purification

  2025cites this paper
• Design-driven optimization of low-cost reagent formulations for reproducible and high-yielding cell-free gene expression

  2025cites this paper
• Cell-free protein synthesis platforms for accelerating drug discovery

  2025cites this paper
• Multifunctional nanoparticle platform for targeted delivery and vaccines

  2025cites this paper
• Computer‐Aided Technology for Bioactive Protein Design and Clinical Application

  2025cites this paper
• Development and Immunological Evaluation of a Multiantigen Thermostable Nanovaccine Adjuvanted with T-Cell-Activating Scaffold for African Swine Fever.

  2024cites this paper
• In situ bio-mineralized Mn nanoadjuvant enhances anti-influenza immunity of recombinant virus-like particle vaccines.

  2024cites this paper
• PHEIGES: all-cell-free phage synthesis and selection from engineered genomes

  2024influential citation
• A Platinum-Protein hybrid nanostructure enables both targeted cancer theragnosis and platinum clearance

  2024cites this paper
• Endogenous capsid-forming protein ARC for self-assembling nanoparticle vaccines

  2024cites this paper
• Bioengineering lipid-based synthetic cells for therapeutic protein delivery.

  2024cites this paper
• An Update on Theoretical and Metrological Aspects of the Surface Hydrophobicity of Virus and Virus‐Like Particles

  2024cites this paper
• Engineering Escherichia coli-Derived Nanoparticles for Vaccine Development

  2024cites this paper
• Decoration of Burkholderia Hcp1 protein to virus-like particles as a vaccine delivery platform

  2024cites this paper
• Next-generation viral nanoparticles for targeted delivery of therapeutics: Fundamentals, methods, biomedical applications, and challenges

  2023influential citation
• Artificial viruses: A nanotechnology based approach

  2023cites this paper
• Study of self-assembling properties of HBc-VLP derivatives aided by molecular dynamic simulations from a thermodynamic perspective

  2023cites this paper
• Rational Design of Virus-like Particles for Nanomedicine

  2023cites this paper
• T Cell Activating Thermostable Self‐Assembly Nanoscaffold Tailored for Cellular Immunity Antigen Delivery

  2023cites this paper
• Preparation and Biological Properties of Oligonucleotide-Functionalized Virus-like Particles

  2023cites this paper
• An Up-to-date Review on Protein-based Nanocarriers in the Management of Cancer.

  2023cites this paper
• Thermal-triggered loading and GSH-responsive releasing property of HBc particles for drug delivery.

  2023cites this paper
• Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model

  2023cites this paper
• GE11-antigen-loaded hepatitis B virus core antigen virus-like particles efficiently bind to TNBC tumor

  2023cites this paper
• Viruses as biomaterials

  2023cites this paper
• A Thermal-Stable Protein Nanoparticle That Stimulates Long Lasting Humoral Immune Response

  2023cites this paper
• Rapid screening and scaled manufacture of immunogenic virus-like particles in a tobacco BY-2 cell-free protein synthesis system

  2023cites this paper
• Cell-free protein synthesis systems for vaccine design and production.

  2023cites this paper
• Non-Neutralizing Epitopes Shade Neutralizing Epitopes against Omicron in a Multiple Epitope-Based Vaccine

  2022cites this paper
• Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches

  2022cites this paper
• A Comprehensive Review on COVID-19: Emphasis on Current Vaccination and Nanotechnology Aspects.

  2022cites this paper
• Virus-like particle vaccinology, from bench to bedside

  2022cites this paper
• Genetically Engineered Viral Vectors and Organic‐Based Non‐Viral Nanocarriers for Drug Delivery Applications

  2022cites this paper
• Cell-free technologies for biopharmaceutical research and production.

  2022cites this paper
• Protein Cages: From Fundamentals to Advanced Applications.

  2022cites this paper
• Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients

  2022cites this paper
• A thermally stable protein nanoparticle that stimulates long lasting humoral immune response

  2022cites this paper
• Development and Preclinical Evaluation of a Near-Infrared Fluorescence Probe Based on Tailored Hepatitis B Core Particles for Imaging-Guided Surgery in Breast Cancer

  2022cites this paper
• Protein-based nanocages for vaccine development.

  2022cites this paper
• Multiple Gene Expression in Cell-Free Protein Synthesis Systems for Reconstructing Bacteriophages and Metabolic Pathways

  2022cites this paper
• ILRI One Health Strategy: Stopping the global rise of high-impact zoonotic disease, foodborne disease and antimicrobial resistance

  2022cites this paper
• Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2

  2022cites this paper
• The Versatile Manipulations of Self-Assembled Proteins in Vaccine Design

  2021cites this paper
• Photoacoustic molecular imaging-escorted adipose photodynamic–browning synergy for fighting obesity with virus-like complexes

  2021cites this paper
• Application of Nanotechnology in the COVID-19 Pandemic

  2021cites this paper
• Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

  2021cites this paper
• Biosynthesis of Escherichia coli adenosine deaminase using cell-free protein synthesis

  2021cites this paper
• Exploration on the expression and assembly of virus-like particles

  2021cites this paper
• Unnatural Amino Acid and its Incorporation in Protein

  2021cites this paper
• Cell-free expression and synthesis of viruses and bacteriophages: applications to medicine and nanotechnology

  2021cites this paper
• The cell-free system: A new apparatus for affordable, sensitive, and portable healthcare

  2021cites this paper
• Chimeric virus-like particles (VLPs) designed from shrimp nodavirus (MrNV) capsid protein specifically target EGFR-positive human colorectal cancer cells

  2021cites this paper
• Strategies for Browning Agent Delivery

  2021cites this paper
• An Ultrastable Virus-Like Particle with a Carbon Dot Core and Expanded Sequence Plasticity.

  2021cites this paper
• 3D Magnetic Field-Controlled Synthesis, Collective Motion, and Bioreaction Enhancement of Multifunctional Peasecod-like Nanochains.

  2021cites this paper
• Virus-inspired nanosystems for drug delivery.

  2021cites this paper
• New generation of viral nanoparticles for targeted drug delivery in cancer therapy

  2021cites this paper
• Tubule-specific protein nanocages potentiate targeted renal fibrosis therapy

  2021cites this paper
• Protein-based antigen presentation platforms for nanoparticle vaccines

  2021cites this paper
• Disulfide stabilization of human norovirus GI.1 virus-like particles focuses immune response toward blockade epitopes

  2020cites this paper
• A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT1 receptors

  2020cites this paper
• Nanoscience in Medicine Vol. 1

  2020cites this paper
• Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines

  2020cites this paper
• Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy

  2020cites this paper
• The New Age of Cell-Free Biology.

  2020cites this paper
• HBc-based virus-like particle assembly from inclusion bodies using 2-methyl-2, 4-pentanediol

  2020cites this paper
• Cell-Free Protein Synthesis: A Promising Option for Future Drug Development

  2020cites this paper
• Flexible on-demand cell-free protein synthesis platform based on a tube-in-tube reactor

  2020cites this paper
• Hitching a Ride: Enhancing Nucleic Acid Delivery into Target Cells Through Nanoparticles

  2020cites this paper
• Virus-like particles: nano-carriers in targeted therapeutics

  2020cites this paper
• Virus-like particle vaccine with B-cell epitope from porcine epidemic diarrhea virus (PEDV) incorporated into hepatitis B virus core capsid provides clinical alleviation against PEDV in neonatal piglets through lactogenic immunity.

  2020cites this paper
• Second career of a biosynthetic enzyme: Lumazine synthase as a virus-like nanoparticle in vaccine development

  2020cites this paper
• In vitro preparation of uniform and nucleic acid free hepatitis B core particles through an optimized disassembly-purification-reassembly process.

  2020cites this paper
• Chemical Strategies to Boost Cancer Vaccines.

  2020cites this paper
• Modular Hepatitis B Virus-Like Particle Platform for Biosensing and Drug Delivery.

  2020cites this paper
• A self-assembled protein nanoparticle serving as a one-shot vaccine carrier

  2020cites this paper
• Dual-Antigen-Loaded Hepatitis B Virus Core Antigen Virus-like Particles Stimulate Efficient Immunotherapy Against Melanoma.

  2020cites this paper
• Development of HBc virus-like particles as modular nanocarrier by intein-mediated trans-splicing.

  2020cites this paper
• Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.

  2019cites this paper
• Synthetic Biology Goes Cell-Free

  2019cites this paper
• Advances in Cell-Free Biosynthetic Technology

  2019cites this paper
• Cell-Free Unnatural Protein Synthesis

  2019cites this paper
• Nanoparticle systems for cancer vaccine.

  2019cites this paper
• Other Emerging Development Trends

  2019cites this paper
• Protein-driven nanomedicines in oncotherapy.

  2019cites this paper
• Cell-free transcription-translation: engineering biology from the nanometer to the millimeter scale.

  2019cites this paper
• Cloning and expression of virus-like particles (VLPs) in microalgal expression systems

  2019influential citation
• One-Pot, Multicomponent Strategy for Designing Lymphoseek-Inspired Hetero-Glycoadjuvant@AuNPs.

  2019cites this paper
• Virus-Like Particles as an Instrument of Vaccine Production

  2019cites this paper
• Advances and Challenges in Cell-Free Incorporation of Unnatural Amino Acids Into Proteins

  2019cites this paper
• Non-canonical amino acid labeling in proteomics and biotechnology

  2019cites this paper
• Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically encoded multiepitope display

  2019cites this paper
• Virus-like nanoparticles as a novel delivery tool in gene therapy.

  2019cites this paper
• Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen

  2018cites this paper
• Strategies to improve the immunogenicity of subunit vaccine candidates

  2018cites this paper